Status | Study |
RECRUITING |
Study Name: A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease. Condition: Chronic Graft Versus Host Disease Date: 2023-11-16 Interventions: Pharmaceutical form:Tablet-Route of administration:oral |
NOT_YET_RECRUITING |
Study Name: Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease Condition: Chronic Graft Versus Host Disease Date: 2023-09-14 Interventions: 200mg PO QD x 24 cycles (28-day cycle) |
RECRUITING |
Study Name: Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease Condition: Chronic Graft Versus Host Disease Date: 2023-08-10 Interventions: Given PO |
Recruiting |
Study Name: Ibrutinib in Combination With Corticosteroids Versus Placebo in Combination With Corticosteroids in Subjects With New Onset Chronic Graft Versus Host Disease (cGVHD) Condition: Chronic Graft Versus Host Disease Date: 2016-10-25 Interventions: Drug: ibrutinib Ibrutinib caps |
Recruiting |
Study Name: Multiple Donor Treg DLI for Severe Refractory Chronic GVHD Condition: Chronic Graft Versus Host Disease Date: 2016-04-20 Interventions: Biological: T reg DLI Purified Treg cells will be obtained |
Recruiting |
Study Name: Efficacy and Tolerability of Entospletinib in Combination With Systemic Corticosteroids as First-Line Therapy in Adults With Chronic Graft Versus Host Disease (cGVHD) Condition: Chronic Graft Versus Host Disease Date: 2016-02-24 Interventions: Drug: Entospletinib Entospleti |
Recruiting |
Study Name: Extracorporeal Photopheresis and Low Dose Aldesleukin in Treating Patients With Steroid Refractory Chronic Graft-Versus-Host Disease Condition: Chronic Graft Versus Host Disease Date: 2015-11-23 Interventions: Biological: Aldesleukin Given |
Recruiting |
Study Name: Evaluation of the Diagnostic Value of PET (18F-FDG) in Chronic Graft Versus Host Disease (cGVH) Condition: Chronic Graft Versus Host Disease Date: 2015-01-23 Interventions: Procedure: PET (18-FDG) Every patient will have a PET |
Recruiting |
Study Name: Extracorporeal Photopheresis Using Theraflex ECP™ for Patients With Refractory Chronic Graft Versus Host Disease (cGVHD) Condition: Refractory Chronic Graft Versus Host Disease (cGVHD) Date: 2015-01-14 Interventions: Device: Photopheresis Theraflex ECP™ The Macopharma (Theraflex ECP™) approach is based on a |
Recruiting |
Study Name: A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory Chronic Graft-versus-Host-Disease Condition: Chronic Graft-versus-host-disease Date: 2015-01-07 Interventions: Procedure: Extracorporeal Photopheresis (ECP) |